If You Invested in Fidelity Disruptive Medicine ETF (FMED)
Looking for the current price? See the FMED quote & overviewWhat $1,000 or $10,000 in FMED Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jun 12, 2023 |
|---|---|---|---|---|
| $1,000 | $1,210 +21% | — | — | $1,295 +30% |
| $10,000 | $12,102 +21% | — | — | $12,951 +30% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-12. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for FMED$1,000 Investment Over Time
FMED vs S&P 500Year-by-Year Returns
FMED annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2023Jun 12 to Dec 29 | $25.28 | $24.22 | -4.2% | -4.2% |
| 2024 | $24.22 | $24.66 | +1.8% | -2.4% |
| 2025 | $24.66 | $27.05 | +9.7% | +7.0% |
| 2026Dec 31, 2025 to Nov 12 | $27.05 | $32.74 | +21.0% | +29.5% |
About Fidelity Disruptive Medicine ETF
NASDAQ
Frequently Asked Questions
Fidelity Disruptive Medicine ETF investment returns
How much would $1,000 invested in Fidelity Disruptive Medicine ETF be worth today?
If you invested $1,000 in Fidelity Disruptive Medicine ETF (FMED) 1 year ago on 2025-11-18, your investment would be worth $1,210 as of 2026-11-12, a +21.0% price return without dividends.
Has Fidelity Disruptive Medicine ETF outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare FMED performance over available time periods.
What is Fidelity Disruptive Medicine ETF's average annual return?
Over the past 1 year, FMED’s share price returned +21.0%, without dividends. Individual years vary a great deal, and FMED’s best recent full year was 2025 (+9.7%) while the worst was 2024 (+1.8%).
For informational and educational purposes only, not investment advice.